Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: A randomized controlled trial

Archives of Internal Medicine

Volumn 170, Issue 17, 2010, Pages 1586-1593

  Pontari, Michel A ^a   Krieger, John N ^b   Litwin, Mark S ^c   White, Paige C ^d   Anderson, Rodney U ^e   McNaughton Collins, Mary ^f   Nickel, J Curtis ^g   Shoskes, Daniel A ^h   Alexander, Richard B ⁱ   O'Leary, Michael ^j   Zeitlin, Scott ^c   Chuai, Shannon ^k   Landis, J Richard ^k   Cen, Liyi ^k   Propert, Kathleen J ^k   Kusek, John W ^l   Nyberg Jr , Leroy M ⁿ   Schaeffer, Anthony J ^m  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MISSISSIPPI   (United States)

^e STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g QUEEN S UNIVERSITY   (Canada)

^h LERNER RESEARCH INSTITUTE   (United States)

ⁱ UNIVERSITY OF MARYLAND   (United States)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

^k UNIVERSITY OF PENNSYLVANIA   (United States)

^l NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^m NORTHWESTERN UNIVERSITY   (United States)

ⁿ NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PREGABALIN; 4 AMINOBUTYRIC ACID; ANALGESIC AGENT;

ADULT; AGED; ARTICLE; CHRONIC PROSTATITIS; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; GASTROINTESTINAL DISEASE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MANTEL HAENSZEL TEST; MCGILL PAIN QUESTIONNAIRE; MULTICENTER STUDY; NATIONAL HEALTH ORGANIZATION; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PAIN; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT DURATION; TREATMENT RESPONSE; URINARY TRACT DISEASE; VISUAL DISORDER; ANALOGS AND DERIVATIVES; CANADA; CHRONIC DISEASE; COMPLICATION; MIDDLE AGED; PELVIC PAIN; PROSTATITIS; TREATMENT OUTCOME; UNITED STATES; UNIVERSITY HOSPITAL;

ADULT; AGED; ANALGESICS; CANADA; CHRONIC DISEASE; DOUBLE-BLIND METHOD; GAMMA-AMINOBUTYRIC ACID; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; PELVIC PAIN; PROSTATITIS; TREATMENT OUTCOME; UNITED STATES;

EID: 77957683070     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.319     Document Type: Article

References (28)

1. Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999;282(3):236-237.
2. Pontari MA, Joyce GF, Wise M, McNaughton-Collins M; Urologic Diseases in America Project. Prostatitis. J Urol. 2007;177(6):2050-2057.
3. Calhoun EA, McNaughton Collins M, Pontari MA, et al; Chronic Prostatitis Collaborative Research Network. The economic impact of chronic prostatitis. Arch Intern Med. 2004;164(11):1231-1236.
4. McNaughton Collins M, Pontari MA, O'Leary MP, et al; Chronic Prostatitis Collaborative Research Network. Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network. J Gen Intern Med. 2001;16(10):656-662.
5. Pontari MA, McNaughton-Collins M, O'Leary MP, et al; CPCRN Study Group. A case-control study of risk factors in men with chronic pelvic pain syndrome. BJU Int. 2005;96(4):559-565.
6. Miller LJ, Fischer KA, Goralnick SJ, et al. Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome. Urology. 2002;59(4):603-608. (Pubitemid 34249905)
7. Desireddi NV, Campbell PL, Stern JA, et al. Monocyte chemoattractant protein-1 and macrophage inflammatory protein-1α as possible biomarkers for the chronic pelvic pain syndrome. J Urol. 2008;179(5):1857-1862.
8. Zhang N, Inan S, Inan S, et al. A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1 [published correction appears in Proc Natl Acad Sci U S A. 2005;102(19):7050]. Proc Natl Acad Sci U S A. 2005;102(12):4536-4541.
9. Yang CC, Lee JC, Kromm BG, Ciol MA, Berger RE. Pain sensitization in male chronic pelvic pain syndrome: why are symptoms so difficult to treat? J Urol. 2003;170(3):823-827.
10. Yilmaz U, Liu YW, Berger RE, Yang CC. Autonomic nervous system changes in men with chronic pelvic pain syndrome. J Urol. 2007;177(6):2170-2174.
11. Crofford LJ, Rowbotham MC, Mease PJ, et al; Pregabalin 1008-105 Study Group. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005;52(4):1264-1273.
12. Dworkin RH, Corbin AE, Young JP Jr, et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2003;60(8):1274-1283.
13. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain. 2004;110(3):628-638. (Pubitemid 39036794)
14. Litwin MS, McNaughton-Collins M, Fowler FJ Jr, et al; Chronic Prostatitis Collaborative Research Network. The National Institutes of Health Chronic Prostatitis Symptom Index: development and validation of a new outcome measure. J Urol. 1999;162(2):369-375.
15. Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). National Cancer Institute Web site. http://ctep.cancer.gov/protocolDevelopment/electronic-applications/docs/ctcaev3. pdf. Published August 9, 2006. Accessed July 20, 2010.
16. Propert KJ, Litwin MS, Wang Y, et al; Chronic Prostatitis Collaborative Research Network (CPCRN). Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). Qual Life Res. 2006;15(2):299-305.
17. Propert KJ, Alexander RB, Nickel JC, et al; Chronic Prostatitis Collaborative Research Network. Design of amulticenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome. Urology. 2002;59(6):870-876.
18. Propert KJ, Mayer RD, Wang Y, et al; Interstitial Cystitis Clinical Trials Group. Responsiveness of symptom scales for interstitial cystitis. Urology. 2006;67(1):55-59.
19. Propert KJ, Payne C, Kusek JW, Nyberg LM. Pitfalls in the design of clinical trials for interstitial cystitis. Urology. 2002;60(5):742-748. (Pubitemid 35300329)
20. Melzack R. The short-form McGill Pain Questionnaire. Pain. 1987;30(2):191-197.
21. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-233. (Pubitemid 126433231)
22. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67(6):361-370.
23. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49(6):822-830. (Pubitemid 27246947)
24. Mehta C, Patel N. Proc-StatXact for SAS Users: Statistical Software for Exact Nonparametric Inference. Cambridge, MA: Cytel Software Corp; 1997.
25. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
26. Alexander RB, Propert KJ, Schaeffer AJ, et al; Chronic Prostatitis Collaborative Research Network. Ciprofloxacin or tamsulosin in men with chronic prostatitis-chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med. 2004;141(8):581-589.
27. Nickel JC, Krieger JN, McNaughton-Collins M, et al; Chronic Prostatitis Collaborative Research Network. Alfuzosin and symptoms of chronic prostatitischronic pelvic pain syndrome. N Engl J Med. 2008;359(25):2663-2673.
28. Pocock SJ, Ware JH. Translating statistical findings into plain English. Lancet. 2009;373(9679):1926-1928.